Who
Jason Marc Adler
Director
Company insider
Files Form 4 as: Director, Cronos Group.
In numbers
- Trades disclosed
- 88
- Buys
- 25
- Sells
- 7
- Bought
- $4.8M
- Sold
- $19.7M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 7 Aug 2020
- Last trade
- 6 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 7 Aug 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —48,859.93 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —48,859.93 at $0.00 | filing |
| 7 Aug 2025filed 11 Aug 2025 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —66,079.3 at $0.00 | filing |
| 8 Aug 2024filed 12 Aug 2024 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —64,655.17 at $0.00 | filing |
| 8 Aug 2023filed 10 Aug 2023 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —85,315.68 at $0.00 | filing |
| 30 May 2023filed 1 Jun 2023 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Bought | $20K11,250 at $1.74 | filing |
| 30 May 2023filed 1 Jun 2023 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Bought | $46K26,250 at $1.74 | filing |
| 25 May 2023filed 30 May 2023 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Bought | $54K30,001 at $1.80 | filing |
| 25 May 2023filed 30 May 2023 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Bought | $126K69,999 at $1.80 | filing |
| 23 May 2023filed 25 May 2023 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Bought | $57K30,001 at $1.90 | filing |
| 23 May 2023filed 25 May 2023 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Bought | $133K69,999 at $1.90 | filing |
| 19 May 2023filed 23 May 2023 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Bought | $57K30,000 at $1.89 | filing |
| 19 May 2023filed 23 May 2023 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Bought | $132K70,000 at $1.89 | filing |
| 18 May 2023filed 22 May 2023 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Bought | $6,1673,426 at $1.80 | filing |
| 18 May 2023filed 22 May 2023 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Bought | $14K7,994 at $1.80 | filing |
| 17 May 2023filed 22 May 2023 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Bought | $30K17,795 at $1.71 | filing |
| 17 May 2023filed 22 May 2023 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Bought | $71K41,505 at $1.71 | filing |
| 16 May 2023filed 17 May 2023 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Bought | $92K53,269 at $1.72 | filing |
| 16 May 2023filed 17 May 2023 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Bought | $39K22,831 at $1.72 | filing |
| 15 May 2023filed 17 May 2023 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Bought | $23K13,300 at $1.76 | filing |
News
Comparing Cronos Group (NASDAQ:CRON) and Eton Pharmaceuticals (NASDAQ:ETON)CRON · dailypolitical.com · 13 Oct 2026Reviewing Cronos Group (NASDAQ:CRON) and Urogen Pharma (NASDAQ:URGN)CRON · tickerreport.com · 13 Oct 2026
0 headlines in the last 90 days name Jason Marc Adler; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.